Clinical Trial Update: A Safety and Tolerability Study of Neural Stem Cells (NR1) in Subjects With Chronic Ischemic Subcortical Stroke (ISS) [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update for NR1 neural stem cells in chronic ischemic subcortical stroke indicates the Phase 1/Phase 2 safety and tolerability study is active but…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stroke

Drugs mentioned

• NR1 Neural Stem Cells (neural stem cells)

Snippet

Sponsor: Gary Steinberg, MD, PhD | Conditions: Ischemic Stroke | Phase 1, Phase 2 | Status: ACTIVE_NOT_RECRUITING